Clinical Trial Update: A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trametinib and panitumumab in RAS/RAF wild-type advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)
• Trametinib (trametinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Colorectal Cancer, KRAS Wildtype | Phase 2 | Status: COMPLETED